BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37715247)

  • 1. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis.
    Pomeshchik Y; Velasquez E; Gil J; Klementieva O; Gidlöf R; Sydoff M; Bagnoli S; Nacmias B; Sorbi S; Westergren-Thorsson G; Gouras GK; Rezeli M; Roybon L
    Acta Neuropathol Commun; 2023 Sep; 11(1):150. PubMed ID: 37715247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common proteomic profiles of induced pluripotent stem cell-derived three-dimensional neurons and brain tissue from Alzheimer patients.
    Chen M; Lee HK; Moo L; Hanlon E; Stein T; Xia W
    J Proteomics; 2018 Jun; 182():21-33. PubMed ID: 29709615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies.
    Pomeshchik Y; Klementieva O; Gil J; Martinsson I; Hansen MG; de Vries T; Sancho-Balsells A; Russ K; Savchenko E; Collin A; Vaz AR; Bagnoli S; Nacmias B; Rampon C; Sorbi S; Brites D; Marko-Varga G; Kokaia Z; Rezeli M; Gouras GK; Roybon L
    Stem Cell Reports; 2020 Jul; 15(1):256-273. PubMed ID: 32589876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal Proteomic Alteration in Triple Transgenic Mouse Model of Alzheimer's Disease and Implication of PINK 1 Regulation in Donepezil Treatment.
    Zhou X; Xiao W; Su Z; Cheng J; Zheng C; Zhang Z; Wang Y; Wang L; Xu B; Li S; Yang X; Pui Man Hoi M
    J Proteome Res; 2019 Apr; 18(4):1542-1552. PubMed ID: 30484658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer's Disease.
    Armijo E; Edwards G; Flores A; Vera J; Shahnawaz M; Moda F; Gonzalez C; Sanhueza M; Soto C
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization.
    Pedrero-Prieto CM; Flores-Cuadrado A; Saiz-Sánchez D; Úbeda-Bañón I; Frontiñán-Rubio J; Alcaín FJ; Mateos-Hernández L; de la Fuente J; Durán-Prado M; Villar M; Martínez-Marcos A; Peinado JR
    Alzheimers Res Ther; 2019 Jun; 11(1):56. PubMed ID: 31253170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer's disease.
    Aladeokin AC; Akiyama T; Kimura A; Kimura Y; Takahashi-Jitsuki A; Nakamura H; Makihara H; Masukawa D; Nakabayashi J; Hirano H; Nakamura F; Saito T; Saido T; Goshima Y
    Neurobiol Dis; 2019 Dec; 132():104603. PubMed ID: 31494281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactolin improves mitochondrial function in Aβ-treated mouse hippocampal neuronal cell line and a human iPSC-derived neuronal cell model of Alzheimer's disease.
    Ayabe T; Takahashi C; Ohya R; Ano Y
    FASEB J; 2022 Apr; 36(4):e22277. PubMed ID: 35319792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer's disease and the role of glial cells.
    Gao Y; Liu J; Wang J; Liu Y; Zeng LH; Ge W; Ma C
    Brain Pathol; 2022 Jul; 32(4):e13047. PubMed ID: 35016256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.
    Velásquez E; Szeitz B; Gil J; Rodriguez J; Palkovits M; Renner É; Hortobágyi T; Döme P; Nogueira FC; Marko-Varga G; Domont GB; Rezeli M
    Front Immunol; 2021; 12():750665. PubMed ID: 34712240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-Induced Pluripotent Stem Cells Ameliorate Cognitive Dysfunction and Reduce Aβ Deposition in a Mouse Model of Alzheimer's Disease.
    Cha MY; Kwon YW; Ahn HS; Jeong H; Lee YY; Moon M; Baik SH; Kim DK; Song H; Yi EC; Hwang D; Kim HS; Mook-Jung I
    Stem Cells Transl Med; 2017 Jan; 6(1):293-305. PubMed ID: 28170178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.